Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 29:9:12.
doi: 10.1186/1472-6904-9-12.

Effect of buspirone on thermal sensory and pain thresholds in human volunteers

Goran Pavlaković  1 , Julija Tigges, Thomas A Crozier
Affiliations
Randomized Controlled Trial

Effect of buspirone on thermal sensory and pain thresholds in human volunteers

Goran Pavlaković et al. BMC Clin Pharmacol. .

Abstract

Background: Buspirone is a partial 5-HT1A receptor agonist. Animal studies have shown that modulation of serotoninergic transmission at the 5-HT1A receptor can induce analgesia in acute pain models. However, no studies have been published so far on the effects of serotonin receptor agonists on pain perception in humans.

Methods: The effects of buspirone (30 mg p.o.) on thermal sensory and pain thresholds were investigated in twelve female volunteers (26 +/- 2 yrs) in a prospective, randomized, double-blind, double-dummy, placebo-controlled study with morphine (10 mg i.v.) as positive control.

Results: Morphine significantly increased the heat pain detection threshold (DeltaT: placebo 1.0 degrees C and 1.3 degrees C, p < 0.05) at 60 minutes. Buspirone caused mild sedation in six participants at 60 minutes, but was without effect on any of the measured parameters.

Conclusion: Buspirone in the maximal recommended dose was without significant effect on thermal pain. However, as it is only a partial agonist at the 5-HT1A receptor and also acts on other receptor types, the negative results of the present study do not rule out a possible analgesic effect of more specific 5-HT1A receptor agonists.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hemodynamic parameters. Hemodynamic parameters 60 and 120 minutes following buspirone and morphine administration: The values are expressed as change in the blood pressure or heart rate from the pre-treatment value. a) Systolic blood pressure change, b) Heart rate change. Blood pressure and heart rate changes following the two drugs were not significantly different than with placebo (p < 0.05). BP0', BP60', BP120' = systolic blood pressure at the time of drug administration (0) and 60 and 120 minutes after drug administration. HR0', HR60', HR120' = heart rate at the time of drug administration (0) and 60 and 120 minutes after drug administration.
Figure 2
Figure 2
Sedation scores. Ramsay sedation scores for the subjects before and 60 and 120 minutes following the drug administration. The initial score always 2 (cooperative and tranquil) in all participants. * = statistical significance of the Ramsay scores compared to pretreatment score (p < 0.05). ** = statistical significance of the Ramsay scores compared to placebo at the same time point (p < 0.05).
Figure 3
Figure 3
Thermal sensory and pain thresholds. The effect of the two drugs (morphine and buspirone) on the tested thermal sensory qualities: a) HDT, b) HPDT, c) CDT and d) CPDT. Data are expressed as means ± SD of the difference between the baseline threshold values measured before and 60 or 120 minutes after the administration. * = statistical significance of change in threshold compared to pretreatment (p < 0.05). HDT = heat detection threshold, HPDT = heat pain detection threshold, CDT = cold detection threshold, CPDT = cold pain detection threshold.
See this image and copyright information in PMC

References

    1. Besson JM, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev. 1987;67:67–186. - PubMed
    1. Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assie MB, et al. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology. 2002;43:945–958. doi: 10.1016/S0028-3908(02)00119-3. - DOI - PubMed
    1. Palm F, Mossner R, Chen Y, He L, Gerlach M, Bischofs S, Riederer P, Lesch KP, Sommer C. Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain. 2008;12:790–797. doi: 10.1016/j.ejpain.2007.11.009. - DOI - PubMed
    1. Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, Hamon M, Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain. 2007;130:235–248. doi: 10.1016/j.pain.2006.11.015. - DOI - PubMed
    1. Fasmer OB, Berge OG, Post C, Hole K. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice. Pharmacol Biochem Behav. 1986;25:883–888. doi: 10.1016/0091-3057(86)90402-8. - DOI - PubMed

Publication types

LinkOut - more resources